Stay updated on Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision label v3.3.4 was added and the previous v3.3.3 label removed in the page's Revision history; the main study details and history entries remain unchanged.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedVersion 33 adds a new 'Study Status' entry to the Record History (dated 2025-12-23), replacing the prior 2025-11-19 entry.SummaryDifference0.3%

- Check31 days agoChange DetectedThe history shows an addition of 'Revision: v3.3.3' and removals of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' in the footer, which are site metadata updates rather than trial-specific content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision note (v3.3.2) and a 'Study Status' entry were added to the Record History, with the latest version counted as 32. The previous revision (v3.2.0) was removed.SummaryDifference0.4%

- Check67 days agoChange DetectedThe government funding lapse notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange DetectedThe page's Record History section shows an updated version entry but no substantive changes to the study details, status, or locations.SummaryDifference0.1%

Stay in the know with updates to Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.